Find Clinical Trial

Home » Find Clinical Trials » A Phase 1, Multicenter, Randomized, Controlled, Open-label, Perioperative Study of AG-120 and AG-881 in Subjects with Recurrent, Non-enhancing, IDH1 Mutant, Low-grade Glioma

A Phase 1, Multicenter, Randomized, Controlled, Open-label, Perioperative Study of AG-120 and AG-881 in Subjects with Recurrent, Non-enhancing, IDH1 Mutant, Low-grade Glioma

← Back

Study Phase	Phase 1

Therapeutic Area	Cancers

Indication	Glioma

Sponsor	Institut de Recherches Internationales Servier

Active substance/ Medical device	AG-120, AG881

Active Substance Code	AG-120, AG881

Protocol Code	AG120-881-C-001

EudraCT Code	2018-001199-39

NCT Code	NCT03343197

Documents and links

Results are not yet available.

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.